We also examined the effects of the bi-steric inhibitors on a genetically engineered mouse model of Tsc2 RCC (Tsc2+/– A/J mice; Figure 6A) and a mouse lung tumor model (Figure 7). This evidence concerns the gene TSC2 and renal cell carcinoma.